Celldex Therapeutics, Inc. — Director's Dealing 2013

Dec 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2013-12-06

Reporting Person: PENNER HARRY JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-06	Common Stock	M	17728	$8.16	Acquired	31144	Direct
2013-12-06	Common Stock	S	17728	$24.50	Disposed	13416	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-06	Non-Qualified Stock Option	$8.16	M	17728	Disposed	2015-03-07	Common Stock (17728)	Direct